Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Dec 2020 17:38

RNS Number : 1361I
Horizon Discovery Group plc
09 December 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Horizon Discovery Group Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

SAND GROVE CAPITAL MANAGEMENT LLP

City and country of registered office (if applicable)

LONDON, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

SAND GROVE OPPORTUNITIES MASTER FUND LTD

SAND GROVE TACTICAL FUND LP

City and country of registered office (if applicable)

CAYMAN ISLANDS

5. Date on which the threshold was crossed or reachedvi:

08/12/2020

6. Date on which issuer notified (DD/MM/YYYY):

09/12/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

7.44%

7.44%

158,363,934

Position of previous notification (if

applicable)

7.46%

7.46%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

11,778,446

7.44%

SUBTOTAL 8. A

11,778,446

7.44%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

LONDON, UK

Date of completion

09/12/2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUKOBRRNUURAA
Date   Source Headline
18th Apr 20167:00 amRNSChange of Adviser
7th Apr 20167:00 amRNSNotice of Results
24th Mar 201612:29 pmRNSAdditional Listing
24th Mar 20168:54 amRNSAdditional Listing
15th Mar 20167:00 amRNSHorizon Discovery hosts symposium on gene editing
2nd Mar 20167:00 amRNSHorizon Discovery Group forms Immuno-oncology JV
26th Jan 20164:04 pmRNSHolding(s) in Company
22nd Jan 20161:21 pmRNSHolding(s) in Company
18th Jan 20167:00 amRNSTrading Update
15th Jan 20164:14 pmRNSAdditional Listing
12th Jan 201610:09 amRNSAdditional Listing
17th Dec 20159:52 amRNSDirector/PDMR Shareholding
11th Dec 20159:23 amRNSAdditional Listing
25th Nov 20157:00 amRNSThree diagnostic agreements worth an initial $3.3m
13th Nov 20157:00 amRNSDirector Dealings
12th Nov 20151:30 pmRNSBoard Change
12th Nov 20157:00 amRNSHolding(s) in Company
12th Nov 20157:00 amRNSHolding(s) in Company
6th Nov 20153:51 pmRNSDirector/PDMR Shareholding
29th Oct 20157:00 amRNSTotal Voting Rights
28th Oct 20157:00 amRNSNew E-Commerce Platform and UK Headquarters
21st Oct 20158:48 amRNSAdditional Listing
15th Oct 20155:44 pmRNSGrant of options under Long Term Incentive Plan
7th Oct 20154:00 pmRNSIssue of Equity
7th Oct 20157:00 amRNSIn-licensing agreement with Servier
22nd Sep 20157:00 amRNSHalf Yearly Report
18th Sep 201510:17 amRNSAdditional Listing
16th Sep 20157:00 amRNSCell Line Licensing Agreement with LakePharma Inc
9th Sep 20157:00 amRNSHZD & Abcam plc Sign License & Supply Agreement
3rd Sep 20157:00 amRNSCancer Research Collaboration with Redx Pharma
3rd Sep 20157:00 amRNSCancer Research Collaboration
1st Sep 201511:49 amRNSAdditional Listing
1st Sep 20157:04 amRNSNotice of Interim Results
27th Jul 20157:00 amRNSHZD To Invest c£10M In Cancer R&D
20th Jul 20157:00 amRNSTrading update
17th Jul 201512:34 pmRNSAdditional Listing
19th Jun 201511:28 amRNSResult of AGM
26th May 20154:46 pmRNS2014 Annual Report and Accounts & AGM Notification
22nd May 20153:28 pmRNSHolding(s) in Company
21st May 20156:04 pmRNSHolding(s) in Company
18th May 201511:50 amRNSResult of General Meeting and Issue of Equity
14th May 20157:00 amRNSDirectorate Change
5th May 20157:01 amRNSCorrection to Results of Placing
1st May 20154:15 pmRNSResults of Placing
1st May 201511:08 amRNSProposed placing and Notice of General Meeting
23rd Apr 20157:00 amRNSHORIZON AND TRANSGENOMIC SIGN OEM AGREEMENT
20th Apr 20157:00 amRNSHorizon & Thermo Fisher Scientific Sign Agreement
14th Apr 20157:07 amRNSPreliminary Results
10th Apr 20153:30 pmRNSAdditional Listing
27th Mar 20158:29 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.